Posttreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction. حسب Lijuan Liu (136685)

Pretreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction. حسب Lijuan Liu (136685)

Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

"…These values significantly decreased in the first postoperative year to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0, and 3.1 ± 2.8; in the second year to 2.1 ± 2.8, 0.4 ± 1.0, 0.0, 0.1 ± 0.3, and 2.6 ± 2.8; and in the third year to 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 (Kruskal–Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g007" target="_blank">Fig 7</a>). …"

Superimposition of the cephalometric tracings obtained before and after treatment of case with mandibular third molar extraction. حسب Lijuan Liu (136685)

Comparison of pretreatment cephalometric variables between premolar extraction and mandibular third molar extraction groups. حسب Lijuan Liu (136685)

Training-induced changes in bipedal stance. حسب Cristina Dolciotti (16317330)

Consolidation of training-induced changes in unipedal stance: 95% Area, Y Sway Amplitude and LFS. حسب Cristina Dolciotti (16317330)

Consolidation of training-induced changes in unipedal stance: Path Length, X Sway Amplitude and Velocity. حسب Cristina Dolciotti (16317330)

Comparison of upper and lower arch crowding between premolar extraction group and the mandibular third molar extraction groups. حسب Lijuan Liu (136685)

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

Comparison of treatment effects between premolar extraction and mandibular third molar extraction groups. * p < 0.05; ** p < 0.01. حسب Lijuan Liu (136685)

a Non-reducing SDS-PAGE of test samples and حسب Vanessa Radtke (1674097)

Yeast encapsulation of a PSI can decrease the phototoxicity against microorganisms and increase the phototoxicity against mosquito larvae. حسب Cole J. Meier (17377064)

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc حسب Lei Wang (6656)

"…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …"

(A) The incidence of OME in the VA group compared to the non-VA group. (B) The rate of tympanostomy tube insertion in the VA group and non-VA group. حسب Miki Kashiwagi (21439684)

Demonstration of decreased Aβ accumulation by DA-9601 treatment. حسب Mijung Lee (397790)

Additional file 8 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study حسب Juliane Schikora (20871169)

Additional file 2 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study حسب Juliane Schikora (20871169)

Additional file 5 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study حسب Juliane Schikora (20871169)